通过可视化靶向纳米载体技术实现基因治疗和免疫治疗相结合的肝癌“诊断治疗一体化鸡尾酒疗法”
序号 | 标题 | 类型 | 作者 |
---|---|---|---|
1 | Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma. | 期刊论文 | Peng H;Zhang Y;Zhou Z;Guo Y;Huang X;Westover KD;Zhang Z;Chen B;Hua Y;Li S;Xu R;Lin N;Peng B;Shen S |
2 | Development of a non-coding-RNA-based EMT/CSC inhibitory nanomedicine for in vivo treatment and monitoring of HCC | 期刊论文 | Guo R;Wu Z;Wang J;Li Q;Shen S;Wang W;Zhou L;Wang W;Cao Z;Guo Y |
3 | 一种靶向介孔聚多巴胺多功能纳米诊疗剂及其制备方法与应用 | 专利 | 曹众;管青青;郭宇;郭若汨 |
4 | Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy | 期刊论文 | Guo Y;Wu Z;Shen S;Guo R;Wang J;Wang W;Zhao K;Kuang M;Shuai X |
5 | Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma. | 期刊论文 | Liu Lingyun;Wu Jian;Guo Yu;Xie Wenxuan;Chen Bin;Zhang Yi;Li Shaoqiang;Hua Yunpeng;Peng Baogang;Shen Shunli |
6 | IL2和IFNγ蛋白共表达的真核表达体系及其制备方法和应用 | 专利 | 郭宇;匡铭;彭穗;王晶;赵坤;彭振伟 |